N-Acetyl cysteine inhibits endothelin-1-induced ROS dependent cardiac hypertrophy through superoxide dismutase regulation

Cell Journal

Volumn 17, Issue 2, 2015, Pages 355-360

  Mushtaq, Sobia ^a   Ali, Tahir ^a   Javed, Qamar ^a   Tabassum, Sobia ^b   Murtaza, Iram ^a  

^a QUAID I AZAM UNIVERSITY   (Pakistan)

^b INTERNATIONAL ISLAMIC UNIVERSITY   (Pakistan)

Author keywords

Cardiac hypertrophy; Endothelin 1; Oxidative stress; Reactive oxygen species; Superoxide dismutase

Indexed keywords

ACETYLCYSTEINE; BRAIN NATRIURETIC PEPTIDE; ENDOTHELIN 1; FREE RADICAL; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ASSAY; EXPERIMENTAL STUDY; HEART FAILURE; HEART VENTRICLE HYPERTROPHY; HISTOLOGY; NEWBORN; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING;

EID: 84936994134     PISSN: 22285806     EISSN: 22285814     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Shohet RV, Kisanuki YY, Zhao XS, Siddiquee Z, Franco F, Yanagisawa M. Mice with cardiomyocyte specific disruption of the endothelin-1 gene are resistant to hyperthyroid cardiac hypertrophy. Proc Natl Acad Sci USA. 2004; 101(7): 2088-2093.
2. Bueno OF, Molkentin JD. Involvement of extracellular signal regulated kinases 1/2 in cardiac hypertrophy and cell death. Circ Res. 2002; 91(9): 776-781.
3. Melnikova NP, Timoshin SS. Effect of endothelin-1 and atrial natriuretic peptide-II on heart morphogenesis in albino rats. Bull Exp Biol Med. 2002; 134 (1): 87-89.
4. Nakao K, Ogawa Y, Suga S, Imura H. Molecular biology and biochemistry of the natriuretic peptide system, I: natriuretic peptides. J Hypertens. 1992; 10(9): 907-912.
5. Mukoyama M, Nakao K, Hosoda K, Suga S, Saito Y, Ogawa Y, et al. Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest. 1991; 87(4): 1402-1412.
6. Ogawa Y, Nakao K, Mukoyama M, Hosoda K, Shirakami G, Arai H, et al. Natriuretic peptides as cardiac hormones in normotensive and spontaneously hypertensive rats. The ventricle is a major site of synthesis and secretion of brain natriuretic peptide. Circ Res. 1991; 69(2): 491-500.
7. Sugawara A, Nakao K, Morii N, Yamada T, Itoh H, Shiono S, et al. Synthesis of atrial natriuretic polypeptide in human failing hearts. Evidence for altered processing of atrial natriuretic polypeptide precursor and augmented synthesis of beta-human ANP. J Clin Invest. 1988; 81(6): 1962-1970.
8. Hama N, Itoh H, Shirakami G, Nakagawa O, Suga S, Ogawa Y, et al. Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction. Circulation. 1995; 92(6): 1558-1564.
9. Tanaka K, Honda M, Takabatake T. Redox regulation of MAPK pathways and cardiac hypertrophy in adult rat cardiac myocyte. J Am Coll Cardiol. 2001; 37(2): 676-685.
10. Lund AK, Peterson SL, Timmins GS, Walker MK. Endothelin-1 mediated increase in reactive oxygen species and NADPH oxidase activity in hearts of aryl hydrocarbon receptor (AhR) null mice. Toxicol Sci. 2005; 88(1): 265-273.
11. Kotake-Nara E, Saida K. Endothelin-2/vasoactive intestinal contractor: regulation of expression via reactive oxygen species induced by CoCl2 and Biological activities including neurite outgrowth in PC12 cells. ScientificWorld-Journal. 2006; 6: 176-186.
12. Daou GB, Srivastava AK. Reactive oxygen species mediate endothelin-1 induced activation of ERK1/2, PKB, and Pyk2 signaling, as well as protein synthesis, in vascular smooth muscle cells. Free Radic Biol Med. 2004; 37(2): 208-215.
13. Hirotani S, Otsu K, Nishida K, Higuchi Y, Morita T, Nakayama H, et al. Involvement of nuclear factor-kappa B and apoptosis signal-regulating kinase 1 in G-protein-coupled receptor agonist-induced cardiomyocyte hypertrophy. Circulation. 2002; 105(4): 509-515.
14. Xu FP, Chen MS, Wang YZ, Yi Q, Lin SB, Chen AF, et al. Leptin induces hypertrophy via endothelin-1 reactive oxygen species pathway in cultured neonatal rat cardiomyocytes. Circulation. 2004; 110(10): 1269-1275.
15. Kubin AM, Skoumal R, Tavi P, Konyi A, Perjes A, Leskinen H, et al. Role of reactive oxygen species in the regulation of cardiac contractility. J Mol Cell Cardiol. 2011; 50(5): 884-893.
16. Xia Z, Kuo KH, Nagareddy PR, Wang F, Guo Z, Guo T, et al. N-acetylcysteine attenuates PKCbeta2 overexpression and myocardial hypertrophy in streptozotocin-induced diabetic rats. Cardiovasc Res. 2007; 73(4): 770-782.
17. Lei S, Liu Y, Liu H, Yu H, Wang H, Xia Z. Effects of N-acetylcysteine on nicotinamide dinucleotide phosphate oxidase activation and antioxidant status in heart, lung, liver and kidney in streptozotocin-induced diabetic rats. Yonsei Med J. 2012; 53(2): 294-303.
18. Sandstrom J, Nilsson P, Karlsson K, Marklund SL. 10-fold increase in human plasma extracellular superoxide dismutase content caused by a mutation in heparin-binding domain. J Biol Chem. 1994; 269(29): 19163-19166.
19. Hayashi I, Morishita Y, Imai K, Nakamura M, Nakachi K, Hayashi T. High-through put spectro photometric assay of reactive oxygen species in serum. Mutat Res. 2007; 631(1): 55-61.
20. Beyer WF Jr, Fridovich I. Assaying for superoxide dismutase activity: some large consequences of minor changes in conditions. Anal Biochem. 1987; 161(2): 559-566.
21. Fischer AH, Jacobson KA, Rose J, Zeller R. Hematoxylin and eosin staining of tissue and cell sections. CSH Protoc. 2008; 2008: pdb.prot4986.
22. Ehmke H, Faulhaber J, Munter K, Kirchengast M, Wiesner RJ. Chronic ETA receptor blockade attenuates cardiac hypertrophy independently of blood pressure effects in renovascular hypertensive rats. Hypertension. 1999; 33(4): 954-960.
23. Ito H, Hiroe M, Hirata Y, Fujisaki H, Adachi S, Akimoto H, et al. Endothelin ETA receptor antagonist blocks cardiac hypertrophy provoked by pressure overload. Circulation. 1994; 89(5): 2198-2203.
24. Keith M, Geranmayegan A, Sole MJ, Kurian R, Robinson A, Omran AS, et al. Increased oxidative stress in patients with congestive heart failure. J Am Coll Cardiol. 1998; 31(6): 1352-1356.
25. Dhalla AK, Hill MF, Singal PK. Role of oxidative stress in transition of hypertrophy to heart failure. J Am Coll Cardiol. 1996; 28(2): 506-514.
26. Spirito P, Seidman CE, McKenna WJ, Maron BJ. The management of hypertrophic cardiomyopathy. N Engl J Med. 1997; 336(11): 775-785.
27. Shimojo N, Jesmin S, Zaedi S, Maeda S, Soma M, Aonuma K, et al. Eicosapentaenoic acid prevents endothelin-1-induced cardiomyocyte hypertrophy in vitro through the suppression of TGF-beta 1 and phosphorylated JNK. Am J Physiol Heart Circ Physiol. 2006; 291(2): H835-845.
28. Van Deel ED, Lu Z, Xu X, Zhu G, Hu X, Oury TD, et al. Extracellular superoxide dismutase protects the heart against oxidative stress and hypertrophy after myocardial infarction. Free Radic Biol Med. 2008; 44(7): 1305-1313.
29. Fiordaliso F, Bianchi R, Staszewsky L, Cuccovillo I, Doni M, Laragione T, et al. Antioxidant treatment attenuates hyperglycemia-induced cardiomyocyte death in rats. J Mol Cell Cardiol. 2004; 37(5): 959-968.
30. Smaga I, Pomierny B, Krzyzanowska W, Pomierny- Chamioło L, Miszkiel J, Niedzielska E, et al. N-acetylcysteine possesses antidepressant-like activity through reduction of oxidative stress: Behavioral and biochemical analyses in rats. Prog Neuropsychopharmacol Biol Psychiatry. 2012; 39(2): 280-287.
31. Uraz S, Tahan G, Aytekin H, Tahan V. N-acetylcysteine expresses powerful anti inflammatory and antioxidant activities resulting in complete improvement of acetic acid-induced colitis in rats. Scand J Clin Lab Invest. 2013; 73(1): 61-66.